PURE Bioscience, Inc.
PUREOTCConsumer Defensive● Active
$0.07
$-0.00(-2.67%)
Market Cap$7328533
P/E Ratio—
52W High$0.14
52W Low$0.04
PURE Bioscience, Inc. (PURE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PURE · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-07 | 2024-07 | 2023-07 | 2022-07 | 2021-07 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.20M | $1.96M | $1.88M | $1.85M | $3.93M |
| Cost of Revenue | $0.90M | $0.81M | $0.91M | $0.85M | $1.85M |
| Gross Profit | $1.30M | $1.15M | $0.97M | $1.00M | $2.08M |
| Gross Margin %(computed) | 59.17% | 58.69% | 51.73% | 53.97% | 52.84% |
| Operating Expenses | |||||
| R&D Expenses | $0.32M | $0.30M | $0.30M | $0.32M | $0.34M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $4.05M |
| Total Operating Expenses | $3.58M | $4.34M | $4.60M | $4.42M | $4.39M |
| Operating Income | ($2.27M) | ($3.13M) | ($3.94M) | ($3.42M) | ($2.31M) |
| Operating Margin %(computed) | -103.18% | -159.50% | -210.07% | -184.84% | -58.85% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.30M | $0.15M | $0.01M | $0.01M | $0.00M |
| Income Before Tax | ($2.40M) | ($3.35M) | ($3.96M) | ($3.49M) | ($2.32M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($2.40M) | ($3.35M) | ($3.96M) | ($3.50M) | ($2.32M) |
| Net Margin %(computed) | -108.95% | -170.66% | -211.03% | -188.72% | -59.05% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.03 | $-0.04 | $-0.04 | $-0.03 |
| Wtd Avg Shares | 111.86M | 111.86M | 111.40M | 88.84M | 87.17M |
| EBITDA | ($2.10M) | ($3.05M) | ($3.83M) | ($3.27M) | ($2.14M) |
| EBITDA Margin %(computed) | -95.28% | -155.22% | -204.05% | -176.58% | -54.57% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more PURE Bioscience, Inc. data
About PURE Bioscience, Inc. (PURE) Income Statement
PURE Bioscience, Inc. (PURE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, PURE reported revenue of $0.00B, gross profit of $0.00B (gross margin 59.17%), and net income of ($0.00B) — a net profit margin of -108.95%.
Frequently asked questions
PURE · 4 questionsPURE Bioscience, Inc. (PURE) reported revenue of $0.00B for 2025, up 12.2% year-over-year.
PURE revenuePURE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09